- About
- PsychU For You
- Topics
- Events
- Content
Prioritizing Goals Of Treatment In Patients Diagnosed With Bipolar I Disorder: Results From A US Patient Survey Using Best-Worst Scaling
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Prioritizing Goals Of Treatment In Patients Diagnosed With Bipolar I Disorder: Results From A US Patient Survey Using Best-Worst Scaling
When treating people with bipolar disorder it is important to understand the patient’s perception and prioritization of their goals of treatment. This webinar will discuss how to develop strategies to assess patient preferences regarding new preventative treatments such as mode of administration and dosing regimen, and explore potential differences in goals of treatment and preferences among selected subgroups of patients with BP-I. Together the presenters will review the results of a survey that asks these questions of people diagnosed with bipolar I disorder and discuss not only the results and outcomes but the potential clinical implications.
Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
MoreJoseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”
Karimah S. B. Lynum, PharmD, MBA, BCPP
Medical Director, US Medical Affairs, Neuroscience, Otsuka America Pharmaceutical
MoreDr. Lynum is a Medical Director in the US Medical Affairs Neuroscience division at Otsuka America Pharmaceutical. After earning her Doctor of Pharmacy degree from Florida A&M University, she began her career at the Philadelphia VA Medical Center as a Clinical Pharmacy Specialist in Psychiatry. She is a board-certified Psychiatric Pharmacist and has a Master of Business Administration degree from Drexel University’s LeBow College of Business. Dr. Lynum leads medical strategy and provides her scientific expertise and support on clinical trial design, scientific communications, and other research-related activities.Speaker Joseph Goldberg is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Karimah Lynum is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
Registration
- PsychU For You
